Exclusive

Publication

Byline

Location

Clinical Trial: EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187934) titled 'EVALUATION OF A FULLY AUTOMATED AI TOOL FOR EMBRYO RANKING' on Sept. 04. Brief Summary: T... Read More


Clinical Trial: Mass Spectrometry-based Immune Profiling in Autoimmune Diseases

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188285) titled 'Mass Spectrometry-based Immune Profiling in Autoimmune Diseases' on April 14. Brief Summa... Read More


Clinical Trial: Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective VASCUL-AID Study

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187700) titled 'Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disea... Read More


Clinical Trial: Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin.

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188441) titled 'Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Inje... Read More


Clinical Trial: The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187674) titled 'The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positi... Read More


Clinical Trial: A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188896) titled 'A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus N... Read More


Clinical Trial: Silver Fir Safety in Healthy Volunteers

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07189143) titled 'Silver Fir Safety in Healthy Volunteers' on Aug. 19. Brief Summary: This study evaluated ... Read More


Clinical Trial: SAGA for Toddlers. Supporting Children's Linguistic and Socio-Emotional Development in Early Childhood Education and Care

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07189104) titled 'SAGA for Toddlers. Supporting Children's Linguistic and Socio-Emotional Development in Ear... Read More


Clinical Trial: Implementation and Evaluation of Bump2Baby and Me+ Programme for Gestational Diabetes Mellitus in Routine Maternity Care Setting.

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07189221) titled 'Implementation and Evaluation of Bump2Baby and Me+ Programme for Gestational Diabetes Mell... Read More


COAST GUARD ISSUES PROPOSED RULE: SAFETY ZONE; PORT MIAMI MAIN SHIPPING CHANNEL, MIAMI, FL

WASHINGTON, Sept. 24 -- Coast Guard has issued a proposed rule called: Safety Zone; Port Miami Main Shipping Channel, Miami, FL. The proposed rule was published in the Federal Register on Sept. 24 by... Read More